Papers by Michael Hawthorne
An entry from the Cambridge Structural Database, the world's repository for small molecule cr... more An entry from the Cambridge Structural Database, the world's repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
European Journal of Cancer and Clinical Oncology, 1991
Fenretinide has been used orally as a chemopreventive retinoid in a trial for women at risk of de... more Fenretinide has been used orally as a chemopreventive retinoid in a trial for women at risk of developing contralateral breast cancer. The levels of fenretinide and its metabolites were measured in the breast tissue obtained at surgery from women in the trial. Fenretinide was concentrated by breast tissue. Two major metabolites were detected in the tissue extract, one co-eluting with N-(4-methoxyphenyl)retinamide (CMPR), and the other, more polar, eluting at 17 min under the conditions used. This metabolite remains unidentified. Division of the breast tissue into epithelial cells and fat fractions revealed that fenretinide and the metabolite at the 17 min peak were concentrated in the epithelial cells, whereas 4-MPR was principally localised in the fat compartment. Thus fat may serve as a storage compartment for the retinoid.
Anticancer research
Brassinin, a phytoalexin, is found in Chinese cabbage. Previously, we showed that brassinin signi... more Brassinin, a phytoalexin, is found in Chinese cabbage. Previously, we showed that brassinin significantly inhibited dimethylbenz(a)anthracene (DMBA)-induced mammary lesions in organ culture. Moreover, it was an effective inhibitor against two stage skin carcinogenesis. In the present study, we synthesized several analogs of brassinin and evaluated their effectiveness in the mouse mammary gland organ culture model. Results showed that cyclobrassinin, also a naturally occurring brassinin analog, was more effective than brassinin. Spirobrassinin and N-ethyl-2,3-dihydrobrassinin also significantly inhibited mammary lesion formation. However, none of the methyl substituted analogs were effective. The effects of brassinin may, in part, be mediated by induction of phase II detoxifying enzymes such as quinone reductase.
Phytochemistry, 2002
Two prenylated flavonoid derivatives, 5-hydroxy-4&amp... more Two prenylated flavonoid derivatives, 5-hydroxy-4'-methoxy-2",2"-dimethylpyrano-(7,8:6",5")flavanone (1) and 5,4'-dihydroxy-[2"-(1-hydroxy-1-methylethyl)dihydrofurano]-(7,8:5",4")flavanone (2), were isolated from an ethyl acetate-soluble extract of the leaves of Macaranga conifera using an in vitro activity-guided fractionation procedure based on the inhibition of cyclooxygenase-2. Also obtained were eight known compounds, 5,7-dihydroxy-4'-methoxy-8-(3-methylbut-2-enyl)flavanone (3), lonchocarpol A (4), sophoraflavanone B (5), 5,7-dihydroxy-4'-methoxy-8-(2-hydroxy-3-methylbut-3-enyl)flavanone (6), tomentosanol D (7), lupinifolinol (8), isolicoflavonol (9), and 20-epibryonolic acid (10). The structures of compounds 1 and 2 were determined using spectroscopic methods. All isolates were tested for their inhibitory effects against both cyclooxygenases-1 and -2, and selected compounds were evaluated in a mouse mammary organ culture assay.
Journal of Tissue Culture Methods, 1997
Mouse mammary glands respond to growth promoting hormones in organ culture. In the presence of in... more Mouse mammary glands respond to growth promoting hormones in organ culture. In the presence of insulin, prolactin, aldostrone, and hydrocortisone, the glands exhibit extensive proliferation within 10 days of culture mimicking the mammary alveolar structures observed during pregnancy. However withdrawal of prolactin and steroids from the medium for an additional 14 days results in the disintegration of the alveolar structures
PloS one, 2014
The present experiments were performed to determine the roles of estrogen receptors α and β (ERα ... more The present experiments were performed to determine the roles of estrogen receptors α and β (ERα and ERβ) in normal and neoplastic development in the mouse mammary gland. In wild-type mice, in vivo administration of estradiol (E) + progesterone (P) stimulated mammary ductal growth and alveolar differentiation. Mammary glands from mice in which the ERβ gene has been deleted (βERKO mice) demonstrated normal ductal growth and differentiation in response to E + P. By contrast, mammary glands from mice in which the ERα gene has been deleted (αERKO mice) demonstrated only rudimentary ductal structures that did not differentiate in response to E + P. EGF demonstrates estrogen-like activity in the mammary glands of αERKO mice: treatment of αERKO mice with EGF + P (without E) supported normal mammary gland development, induced expression of progesterone receptor (PR), and increased levels of G-protein-coupled receptor (GPR30) protein. Mammary gland development in βERKO mice treated with EGF ...
Phytochemistry, 2001
A triterpenoid, 3beta-cis-p-coumaroyloxy-2alpha,23-dihydroxyolean-12-en-28-oic acid (1), and two ... more A triterpenoid, 3beta-cis-p-coumaroyloxy-2alpha,23-dihydroxyolean-12-en-28-oic acid (1), and two natural products, 3beta-trans-p-coumaroyloxy-2alpha,23-dihydroxyolean-12-en-28-oic acid (2) and 23-trans-p-coumaroyloxy-2alpha,3beta-dihydroxyolean-12-en-28-oic acid (3), were isolated from a chloroform-soluble extract of the stems of Eugenia sandwicensis, along with 10 known compounds. Of these compounds, 2 showed significant inhibitory activity (79.2% at 4 microg/ml) in a 7,12-dimethylbenz[a]anthracene-induced mouse mammary organ culture assay system of relevance to cancer chemoprevention. Gallic acid was isolated as an antioxidative constituent of an ethyl acetate-soluble extract of E. sandwicensis stems. Isolates 1-3 were characterized on the basis of spectral and chemical evidence.
Pharmaceutical Biology, 2002
Prevention of cancer by natural and synthetic non-toxic chemopreventive agents has become a major... more Prevention of cancer by natural and synthetic non-toxic chemopreventive agents has become a major research area in the past 15 years. The naturally occurring chemopreventive agents from the herbal medicine and edible plants can be evaluated in a variety of bioassays and identified for their activity as cancer preventive agents. We have adapted a mouse mammary gland organ culture assay (MMOC) for evaluating chemically pure chemopreventive agents for their activity to inhibit 7,12-dimethylbenz(a)anthracene (DMBA)induced mammary alveolar lesions (MAL). Here, we report a list of 32 agents that are found in the herbs or edible foods and showing inhibition of more than 55% in MMOC. From the studies reported in the literature it appears that there is a good correlation between the effects in MMOC and effects observed with in vivo carcinogenesis models. Recently, we have modified the MMOC assay to evaluate efficacy of chemopreventive agents specifically the ones that may have anti-estrogenic activity. Thus, MMOC provides a valuable tool for preliminary evaluation of chemopreventive agents prior to conducting a long-term animal carcinogenesis studies.
Nutrition and Cancer, 2001
Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultur... more Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultures were used to purify 12 phenols: the stilbenoids trans-astringin, trans-piceid (2), trans-resveratroloside, trans-resveratrol, trans-piceatannol, cis-resveratroloside, cis-piceid, and cisresveratrol; the flavans (+)-catechin, (-)-epicatechin, and epicatechin 3-O-gallate; and the flavan dimer procyanidin B2 3¢-O-gallate. These compounds were evaluated for potential to inhibit cyclooxygenases and preneoplastic lesion formation in carcinogen-treated mouse mammary glands in organ culture. At 10 µg/ml, trans-astringin and trans-piceatannol inhibited development of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in mouse mammary glands with 68.8% and 76.9% inhibition, respectively, compared with untreated glands. The latter compound was the most potent of the 12 compounds tested in this assay, with the exception of trans-resveratrol (87.5% inhibition). In the cyclooxygenase (COX)-1 assay, trans isomers of the stilbenoids appear to be more active than cis isomers: transresveratrol [50% inhibitory concentration (IC 50) = 14.9 µM, 96%] vs. cis-resveratrol (IC 50 = 55.4 µM). In the COX-2 assay, among the compounds tested, only trans-and cis-resveratrol exhibited significant inhibitory activity (IC 50 = 32.2 and 50.2 µM, respectively). This is the first report showing the potential cancer-chemopreventive activity of transastringin, a plant stilbenoid recently found in wine. trans-Astringin and its aglycone trans-piceatannol were active in the mouse mammary gland organ culture assay but did not exhibit activity in COX-1 and COX-2 assays. trans-Resveratrol was active in all three of the bioassays used in this investigation. These findings suggest that trans-astringin and trans-piceatannol may function as potential cancerchemopreventive agents by a mechanism different from that of trans-resveratrol.
Molecular and Cellular Biochemistry, 2012
The nuclear receptor peroxisome proliferatoractivated receptor gamma (PPARc) plays a central role... more The nuclear receptor peroxisome proliferatoractivated receptor gamma (PPARc) plays a central role in regulating metabolism, including interaction with the estrogen receptor-a (ERa). Significantly, PPARc activity can be modulated by small molecules to control cancer both in vitro and in vivo (Yin et al., Cancer Res 69:687-694, 2009). Here, we evaluated the effects of the PPARc agonist GW7845 and the PPARc antagonist GW9662 on DMBAinduced mammary alveolar lesions (MAL) in a mouse mammary organ culture. The results were as follows: (a) the incidence of MAL development was significantly inhibited by GW 7845 and GW 9662; (b) GW9662 but not GW7845, in the presence of estradiol, induced ER and PR expression in mammary glands and functional ERa in MAL; (c) while GW9662 inhibited expression of adipsin and ap2, GW 7845 enhanced expression of these PPARc-response genes; and (d) Tamoxifen caused significant inhibition of GW9662 treated MAL, suggesting that GW9662 sensitizes MAL to antiestrogen treatment, presumably through rendering functional ERa and induction of PR. The induction of ERa by GW9662, including newer analogs, may permit use of anti-ER strategies to inhibit breast cancer in ER-patients.
Journal of Natural Products, 2003
A new cassane diterpene, dipteryxic acid (1), and a new isoflavonolignan, 5-methoxyxanthocercin A... more A new cassane diterpene, dipteryxic acid (1), and a new isoflavonolignan, 5-methoxyxanthocercin A (2), as well as four known active compounds, isoliquiritigenin (3), 6,4′-dihydroxy-3′-methoxyaurone (4), sulfuretin (5), and (()-balanophonin (6), and five known inactive compounds, butin, eriodictyol, 7-hydroxychromone, 7,3′-dihydroxy-8,4′-dimethoxyisoflavone, and (-)-lariciresinol, were isolated from an ethyl acetate-soluble extract of the seeds of Dipteryx odorata, using a bioassay based on the induction of quinone reductase (QR) in cultured Hepa 1c1c7 mouse hepatoma cells to monitor chromatographic fractionation. The structures of compounds 1 and 2 were elucidated by spectroscopic data interpretation. Single-crystal X-ray diffraction analysis was used to confirm the relative stereochemistry of compound 1. Selected compounds (3-5) were evaluated in a mouse mammary organ culture assay, with isoliquiritigenin (3) found to exhibit 76% inhibition at a dose of 10 µg/mL. Dipteryx odorata (Aubl.) Willd. (syn. Coumarouna odorata Aubl.; Leguminosae) is a tall arboreal species native to Central America and northern South America and commonly known as the "tonka bean" tree. 1 A commercial market exists for the use of extractives of tonka beans in flavoring snuff, cigarettes, cigars, cocoa, and confectionery and as an ingredient of perfumes, liqueurs, sachet powders, and cosmetics. 1,2 The beans also yield a high percentage of a solid fat known as "tonka butter", which is used in flavoring foods. 1 Previous phytochemical investigations on this plant have resulted in the isolation of coumarins, 2,3 cassane diterpenoids, 4 isoflavonoids, 5,6 fatty acids, 7 and lupane triterpenoids. 7 In an ongoing project directed toward the discovery of novel, naturally occurring cancer chemo
Journal of Natural Products, 2003
A new butenylflavanone, (2S)-5-hydroxy-7-methoxy-8-[(E)-3-oxo-1-butenyl]flavanone (1), and a new ... more A new butenylflavanone, (2S)-5-hydroxy-7-methoxy-8-[(E)-3-oxo-1-butenyl]flavanone (1), and a new rotenoid, 4′,5′-dihydro-11,5′-dihydroxy-4′-methoxytephrosin (2), as well as three active flavonoids of previously known structure, isoliquiritigenin (3), genistein (4), and chrysoeriol (5), along with nine known inactive compounds, R-toxicarol (6), sumatrol, 6a,12a-dehydro-R-toxicarol, 11-hydroxytephrosin, obovatin, marmesin, lupenone, benzyl benzoate, and benzyl trans-cinnamate, were isolated from an ethyl acetatesoluble extract of the stems of Tephrosia toxicaria, using a bioassay based on the induction of quinone reductase (QR) in cultured Hepa 1c1c7 mouse hepatoma cells to monitor chromatographic fractionation. The structures of compounds 1 and 2 were elucidated by spectroscopic data interpretation. All isolates were evaluated for their potential cancer chemopreventive properties utilizing an in vitro assay to determine quinone reductase induction. Selected compounds were tested in a mouse mammary organ culture assay to evaluate the inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced preneoplastic lesions.
Journal of Natural Products, 2002
Activity-guided fractionation of an ethyl acetate extract of the aerial parts of Tithonia diversi... more Activity-guided fractionation of an ethyl acetate extract of the aerial parts of Tithonia diversifolia, using an antiproliferation bioassay performed with human colon cancer (Col2) cells, led to the isolation of three new sesquiterpenoids, 2alpha-hydroxytirotundin (1), tithofolinolide (2), and 3alpha-acetoxydiversifolol (3), along with eight known sesquiterpene lactones, 3beta-acetoxy-8beta-isobutyryloxyreynosin (4), tagitinin C (5), 1beta,2alpha-epoxytagitinin C (6), 4alpha,10alpha-dihydroxy-3-oxo-8beta-isobutyryloxyguaia-11(13)-en-12,6alpha-olide (7), 3alpha-acetoxy-4alpha-hydroxy-11(13)-eudesmen-12-oic acid methyl ester, 17,20-dihydroxygeranylnerol, tagitinin A, and tirotundin. These isolates were evaluated for their potential as cancer chemopreventive agents, by measuring antiproliferative activity in Col2 cells and induction of cellular differentiation in human promyelocytic leukemia (HL-60) cells. Selected compounds were then investigated for their ability to inhibit 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in a mouse mammary organ culture assay. Among these isolates, 5 and 6 showed significant antiproliferative activity, 2, 4, and 7 induced HL-60 cellular differentiation, and 4 significantly inhibited (63.0% at 10 microg/mL) lesion formation in the mouse mammary organ culture assay. The chemical structures of 1-3 were elucidated by spectroscopic analysis. The absolute configurations of 1 and 2 were determined by Mosher ester methodology.
Journal of Natural Products, 2002
JNCI Journal of the National Cancer Institute, 2001
Journal of the National Cancer Institute, 2000
Background: Although the active form of vitamin D, i.e., 1,25-dihydroxyvitamin D 3 , is a potent ... more Background: Although the active form of vitamin D, i.e., 1,25-dihydroxyvitamin D 3 , is a potent cell-differentiating agent, its use in cancer prevention or therapy is precluded because it induces excessive blood calcium levels (hypercalcemia). However, less calcemic or noncalcemic synthetic analogues of vitamin D 3 are poorly effective against mammary carcinogenesis. We synthesized an analogue of vitamin D 5 , 1␣hydroxy-24-ethylcholecalciferol (1␣hydroxyvitamin D 5), which was less calcemic than 1,25-dihydroxyvitamin D 3 and prevented the development of precancerous lesions in mammary glands. Here, we evaluate its efficacy in an experimental rat mammary carcinogenesis model. Methods: Sprague-Dawley rats were treated with 1␣hydroxyvitamin D 5 beginning 2 weeks before carcinogen treatment. Animals received an intravenous injection of Nmethyl-N-nitrosourea at 80 days of age and continued to receive dietary 1␣hydroxyvitamin D 5 for an additional 105 days. Tumor incidence and multiplicity were determined, and plasma concentrations of calcium and phosphorus were measured. The efficacy of 1␣-hydroxyvitamin D 5 at different stages of carcinogenesis was determined in mouse mammary gland organ culture. All statistical tests were two-sided. Results: The tumor incidence was reduced from 80% (95% confidence interval [CI] = 51.9%-95.7%) in control rats to 53.3% (95% CI = 26.6%-78.8%) and 46.6% (95% CI = 21.3%-73.4%) in rats treated with 1␣-hydroxyvitamin D 5 at 25 g/kg diet and 50 g/kg diet, respectively. The tumor multiplicity was reduced from 1.6 tumors per rat to 1.2 (95% CI for the difference = −0.45 to 1.25; P = .34) and 0.8 (95% CI for the difference = 0.14-1.46; P = .02), respectively. There was no statistically significant increase in the plasma calcium or phosphorus concentration at either dose level. The vitamin D 5 analogue was effective during both the initiation and the promotion stages of mammary lesion formation in organ culture. Conclusion: Our findings indicate that 1␣hydroxyvitamin D 5 reduces the incidence of mammary carcinogenesis in vivo. This analogue appears to be a good candidate for further development as a chemopreventive agent. [
Journal of Agricultural and Food Chemistry, 2002
... Dae Sik Jang, † Eun Jung Park, † Michael E. Hawthorne, ‡ Jose Schunke Vigo, § James G. Graham... more ... Dae Sik Jang, † Eun Jung Park, † Michael E. Hawthorne, ‡ Jose Schunke Vigo, § James G. Graham, † Fernando Cabieses, § Bernard D. Santarsiero, † Andrew D. Mesecar, † Harry HS Fong, † Rajendra G. Mehta, ‡ John M. Pezzuto, † and A. Douglas Kinghorn* †. ...
European Journal of Cancer, 1998
A clinical trial of N-[4-hydroxyphenyl]retinamide (4-HPR) has been in progress for the past 4 yea... more A clinical trial of N-[4-hydroxyphenyl]retinamide (4-HPR) has been in progress for the past 4 years to evaluate its role in chemoprevention of breast cancer. However, it is currently not known whether the eVect of 4-HPR in breast cells is mediated by 4-HPR directly or through one of its metabolites. In this report, we investigated in vivo and in vitro eVects of 4-HPR on three diVerent breast carcinoma cells and two diVerent melanoma cell lines. In vitro, the growth of all three breast carcinoma cell lines was inhibited by 4-HPR. Only one of two melanoma cell lines (UISO-Mel-1) showed growth inhibition to 4-HPR. The cell lines sensitive to 4-HPR in vitro also showed inhibition to 4-HPR in a xenograft model. Dietary 4-HPR (0.5 mmol/kg diet) reduced the growth of UISO-BCA-1 xenografts in female athymic mice, but had no eVect on UISO-Mel-6 xenografts. Metabolism investigations of the 4-HPRsensitive and insensitive cell lines indicated that N-[4-methoxyphenyl]retinamide (4-MPR), the major metabolite of 4-HPR, was detected only in cells sensitive to 4-HPR. Further in vitro studies with 4-MPR suggested that it is not an active metabolite of 4-HPR as it failed to inhibit growth of 4-HPRresistant UISO-Mel-6 cells, and showed no dose-dependent inhibition of 4-HPR-sensitive breast carcinoma and melanoma cell lines. Our results in the present study indicate that, although 4-MPR is not an active metabolite of 4-HPR, detection of this metabolite in the malignant cells may serve as an indirect biomarker to predict response of cells to 4-HPR.
Drug and Chemical Toxicology, 2002
The present study provides a correlation of the antimutagenic and chemopreventive activity of the... more The present study provides a correlation of the antimutagenic and chemopreventive activity of the barks of two commonly observed plants viz. Acacia auriculiformis and Acacia nilotica. We used the Ames antimutagenicity assay and the mouse mammary gland organ culture (MMOC) model. The plants were extracted with organic solvents to obtain chloroform fractions and acetone extracts. The antimutagenic activity was determined in two different strains using both direct-acting [4-nitro-o-phenylenediamine (NPD) or sodium azide] and indirect-acting [2-aminofluorene (2AF)] mutagens. The anticarcinogenic activity was evaluated based on the development of preneoplastic lesions in response to the chemical carcinogen 7,12-dimethylbenz[a]anthracene (DMBA). The results showed that the activity resulting from the 2AF mutagen was selectively greater than the activity from the direct-acting mutagens. Moreover, in general, acetone extracts were more potent in suppressing mutagenesis than the chloroform extracts. The antimutagenicity results obtained with extracts using the 2AF--TA100 system were comparable to the chemopreventive results with DMBA-induced mammary lesions. The order of activity in both tests was A. nilotica > A. auriculiformis. These results exhibited a good correlation between the antimutagenesis assay and the MMOC model, suggesting that these plants may contain active chemopreventive agents.
Carcinogenesis, 1995
Brassinin [3-(S-methyldithiocarbamoyl)aminomethyl indole], a phytoalexin first identified as a co... more Brassinin [3-(S-methyldithiocarbamoyl)aminomethyl indole], a phytoalexin first identified as a constituent of cabbage, was synthesized and evaluated for cancer chemopreventive activity. Dose-dependent inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced preneoplastic lesion formation was observed with mouse mammary glands in organ culture, as was dose-dependent inhibition of DMBAinduced mouse skin tumors that were promoted by treatment with 12-0-tetradecanoylphorbol-13-acetate. Cyclobrassinin is a biologically derived product of the oxidative cyclization of brassinin, and was as active as the parent compound in inhibiting the formation of preneoplastic mammary lesions in culture; however, 2-methylbrassinin was not significantly active in this process. Therefore, oxidative cyclization may be an effective metabolic activation step. As judged by these tumor inhibition studies in conjunction with potential to induce phase II enzymes in mice or cell culture, brassinin may be effective as a chemopreventive agent during both the initiation and promotion phases of carcinogenesis. This is the first report documenting the chemopreventive potential of structurally novel indole-based phytoalexins that are naturally occurring in cruciferous vegetables, and the synthetic route described herein has proven amenable for scale-up production. The bifunctional structural nature of brassinin, bearing both an indole nucleus and a dithiocarbamoylaminomethyl moiety, is notably similar to the individual structural elements of other known chemopreventive agents such as indole-3-carbinol or benzylisothiocyanate. The favorable biological activity demonstrated by the compound may originate from the presence of these two moieties.
Uploads
Papers by Michael Hawthorne